Objective: To analyse the effect of differentiation on disease-free survival (DFS) and overall survival (OS) in patients with stage I adenocarcinoma of the endometrium. Patients and methods: From 1979 to 1995, 350 patients with FIGO stage IA-IC with well (G1), moderately (G2) or poorly (G3) differentiated tumors were treated with surgery and high dose-rate brachytherapy with or without external radiation. Median age was 65 years (39-86 years). Results: The 5-year DFS was 8863% for the G1 tumors, 7764% for the G2 tumors, and 6767% for the G3 tumors (P50.0049). With regard to the events contributing to DFS, the 5-year cumulative percentage of local relapse was 4.6% for the G1 tumors, 9.0% for the G2 tumors, and 4.6% (P50.027) for the G3 tumors. Cumulative percentage of metastasis was 1.4, 6.3 and 7.2% (P,0.001), respectively, whereas percentages of death were 6.0, 7.9 and 20.7% (P,0.001). The 5-year OS was 9163, 8364 and 7667%, respectively (P50.0018). In terms of multivariate hazard ratios (HR), the relative differences between the three differentiation groups correspond to an increase of 77% of the risk of occurrence of either of the three events considered for the DFS (HR51.77,), (P50.078) for the G2 tumors and of 163% (HR52.63,), (P50.009) for the G3 tumors with respect to the G1 tumors. The estimated relative hazards for OS are, respectively, in line with those for DFS: HR51.51 (P50.282) for the G2 tumors; and HR53.37 (P50.003) for the G3 tumors. Conclusion: Patients with grade 1 tumors are those least exposed to either local relapse, metastasis, or death. In contrast patients with grade 2 tumors seem to be at higher risk of metastasis, whereas patients with grade 3 tumors appear at higher risk of death. Since we have looked at the first of three competing events (local relapse, metastasis and death), this suggests that patients with grade 3 tumors probably progress to death so fast that local relapse, if any, cannot be observed.
Introduction
based on the myometrial invasion only, independently of cell differentiation. Cell differentiation has been shown to be one of the most important prognostic factors in carcinoma of the endometrium [1] [2] [3] [4] . In this retrospective analysis we 2. Patients and methods aimed to investigate the effect of grade on disease control in FIGO stage I patients [5] , who were treated with a 2. [10] , and their corresponding standard errors (SEs) with IA 67 (19) Greenwood's formula [11] . For the univariate analysis the IB
(53)
P values from the log-rank test are reported [12] . Esti-IC 97 (28) mated hazard ratios (HR) for DFS and OS, their 95% Values of HR greater than unity indicate increased rates of (G3), according to the WHO cellular differentiation [5] .
any of the events contributing to death (or of death for OS) Slides were reviewed by two pathologists.
with respect to the chosen reference category (for which HR51 by definition). The probability that local progres-2.2. Treatment sion or metastasis or death occurs before any specified time has been estimated by means of cumulative incidence All patients underwent total extrafascial hysterectomy functions [14] . For the sake of interpretation we point out and bilateral salpingo-oophorectomy. Postoperative treatthat one minus the sum of such probabilities (local relapse, ment strategy was planned on the pathology report of the metastasis, death), at any given point in time, corresponds myometrial invasion only, independently of the cellular to the probability of being alive and disease-free as differentiation. Peritoneal washing was not routinely obobtained from the Kaplan-Meier estimate of the DFS. tained and lymph nodes dissection was very uncommon.
Appropriate statistical methods have been used for comAll 350 patients received vaginal vault irradiation. In paring cumulative incidences allowing for stratification addition 56 / 186 patients with stage IB greater than 30% factors [15] . All probability values are for two-sided tests. myometrial infiltration, and all 97 patients with stage IC For the purpose of the analyses, observations have been received external irradiation.
censored at 5 years in order to limit the effect of competing causes of mortality and also to avoid having 2.3. Radiation therapy only patients registered during the earlier periods contribute to the right tail of the curves. Four weeks after surgery, external irradiation was given on the pelvic volume with a linear accelerator (6-18 MeV) for a total dose of 4500 cGy fractionated at a daily dose of 3. Results 180-200 cGy [6] [7] [8] . The reference point for dose prescription was at the intersection of the four beams. The upper 3.1. Association among patient characteristics limit of the pelvic volume was defined by a line passing through the L5-S1 interspace. The lateral borders were Age was associated with tumor stage. 
Statistical methods
The median follow-up was in excess of 7 years. As explained in Section 2, DFS and OS have been censored at The primary endpoint of this retrospective study was 5 years. A total of 55 events have been observed by the disease-free survival (DFS), which was defined as time fifth year. The 5-year DFS was 8068%. When considering from surgery to the first of the three competing events:
sub-groups, the 5-year DFS was 8863% for the G1 group, G1 group. These and additional multivariate results are displayed in Table 2 . Local relapse was defined as vaginal and / or latero-pelvic recurrence.
Overall survival analysis
The 5-year overall survival was 84.862%. When consid-3.3. Cumulative incidence analysis ering sub-groups, the 5-year OS was 9163% for the G1 group, 8364% for the G2 group, and 67.7% for the G3 In order to better investigate the effect of grade on the group (P50.0018). In terms of multivariate hazard ratio pattern of occurrence of the events contributing to DFS (HR), the relative difference between the three groups (local relapse, metastasis and death), we have estimated the corresponds to a non-significant increase of 51% of the cumulative incidence of each of these competing events risk of death for the G2 group (HR51.51, 95% Cl [0.71-individually. The results are summarized in (Table 2) . grade 2, and 4.6% for grade 3 (P50.027). Similarly, such percentages were 1.4, 6.3 and 7.2% (P,0.001) for metastasis, and 6.0, 7.9 and 20.7% (P,0.001) for deaths. The 4. Discussion cumulative incidence curves are displayed in Figs. 1-3 . Fig. 1 for local recurrence shows a rapid increase of the Our study confirms the prognostic importance of cell curve of the grade 2 tumors during the first year after differentiation on disease-free survival (DFS) and overall treatment, and a slower increase and subsequent leveling survival (OS) of adenocarcinoma of the endometrium. The off of the curves in the G1 and G3 groups by the third relative shapes of the cumulative incidence curves suggest year. Fig. 2 for distant metastasis shows a slow increase that the strong reduction in DFS beyond the first year after and subsequent levelling off of the curves in the G2 and treatment for patients with G3 differentiation can be G3 groups at three years. As concern deaths, Fig. 3 attributed to death. As in other series, well-differentiated suggests that they continue to accumulate over time in all (G1) tumors were easily locally controlled, resulting in a differentiation groups, but again much faster for G3. The longer survival. In contrast, moderately (G2) and poorly 5-year percentage of deaths is almost triple compared to (G3) differentiated tumors were characterised by metaswhat has been observed in the G1 and G2 groups.
tases and death, respectively [1, [16] [17] [18] [19] [20] [21] [22] . G2 patients pro- Table 2 Cox's analysis fitted to the overall survival (OS) and disease-free survival (DFS) gressed at a relatively slow pace, possibly allowing for the detection of local relapse and metastases. On the other hand G3 patients, in whom a high mortality has been observed as opposed to a low rate of local or distant metastases, were probably prone to a rather fast disease progression, in which only the final stage of the evolution, death, was unfortunately detected. Factors associated with the high grade histological variant that may have a bearing on prognosis include a tendency for higher mean age at diagnosis, a greater incidence of both deep myometrial invasion and lymph node involvement [3] , and a high risk of clinical understaging as well as a higher rate of vaginal recurrences [4] . Age at diagnosis did not appear as a significant prognostic factor, though for both OS and DFS the estimated HRs showed a trend in the expected direction. This contrasts with other papers showing that age has a prognostic impact [18, 23] . Our small number of events might not have allowed us to detect this effect, possibly of small magnitude. One might not exclude a bias in the results due to competing causes of death especially acting in older age groups. Our observations cover a time span of over 15 years during which cause of death attribution has not been performed systematically and according to consistent standards. Even if cause of death was available for all patients, we would question its precision and especially so for older patients. Additionally, the focus of the report is on tumor grade, which was not significantly associated
